Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000099 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 6, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
15,000
Total Value
$1,432,705.05
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 3, 2026 | Sale | 800 | $93.97 | $75,176.00 | 581,740 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 3, 2026 | Sale | 7,157 | $95.10 | $680,630.70 | 574,583 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 3, 2026 | Sale | 5,635 | $95.93 | $540,565.55 | 568,948 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 3, 2026 | Sale | 1,392 | $96.82 | $134,773.44 | 567,556 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 3, 2026 | Sale | 16 | $97.46 | $1,559.36 | 567,540 | Direct | โ | View Details |